"Glioblastoma Multiforme (GBM) is the most malignant and common primary brain tumor. Despite improvements in clinical treatment, the five-year survival rate is only 10%. In recent years, given the increased availability of omic data, the analysis of cancer datasets has seen a change in emphasis from non-genetic factors to understanding the genetic factors contributing to the disease. The goal of this study is to jointly model time to death of GBM patients with clinical and demographic covariates along with target SNP and GE." -- Abstract.
Read
